Literature DB >> 16600167

Early mid-trimester serum relaxin, soluble CD163, and cervical length in women at high risk for preterm delivery.

Ida Vogel1, Alice R Goepfert, Holger J Møller, Suzanne Cliver, Poul Thorsen, William W Andrews.   

Abstract

OBJECTIVE: The purpose of this study was to evaluate the relationship between serum concentrations of relaxin and soluble CD163 with cervical length and preterm delivery in women with previous spontaneous preterm delivery. STUDY
DESIGN: Sixty-one of 69 pregnant women with a previous spontaneous preterm had serum relaxin and soluble CD163 measured at week 16 (range, 12-25 weeks). End points were cervical length and gestational age at delivery.
RESULTS: Of the 61 women, 26% had >1 previous spontaneous preterm delivery; 84% were black; 87% were unmarried; 13% were smokers, and 39% were delivered before 37 weeks of gestation. Neither relaxin (median, 368 ng/L; range, 83-1493 ng/L) nor soluble CD163 (2.4 mg/L; range, 0.86-6.85 mg/L) correlated with cervical length or gestational age at delivery. Black women had higher relaxin levels (436 vs 205 ng/L; P = .002), but soluble CD163 levels were similar among racial groups.
CONCLUSION: Relaxin and soluble CD163 measured at 16 weeks of gestation are not clinically useful predictors of short cervical length or preterm delivery in women with a previous spontaneous preterm delivery.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16600167     DOI: 10.1016/j.ajog.2005.12.009

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  5 in total

1.  Expression of serum sCD163 in patients with liver diseases and inflammatory disorders.

Authors:  Jing Wang; Ye Yu; Ying Yang; Shan Shan Wu; Hai Hong Zhu; Yan Ning Liu; Wei Xia Liu; Ying Hu; Wei Wu; Cai Xia Xia; Zhi Chen
Journal:  Int J Clin Exp Pathol       Date:  2015-07-01

2.  Genetic associations of relaxin: preterm birth and premature rupture of fetal membranes.

Authors:  Frederico G Rocha; Thomas P Slavin; Dongmei Li; Maarit I Tiirikainen; Gillian D Bryant-Greenwood
Journal:  Am J Obstet Gynecol       Date:  2013-05-10       Impact factor: 8.661

3.  Recombinant human relaxin versus placebo for cervical ripening: a double-blind randomised trial in pregnant women scheduled for induction of labour.

Authors:  Gerson Weiss; Sam Teichman; Dennis Stewart; David Nader; Susan Wood; Peter Breining; Elaine Unemori
Journal:  BMC Pregnancy Childbirth       Date:  2016-09-05       Impact factor: 3.007

4.  Is there a maternal blood biomarker that can predict spontaneous preterm birth prior to labour onset? A systematic review.

Authors:  Kylie K Hornaday; Eilidh M Wood; Donna M Slater
Journal:  PLoS One       Date:  2022-04-04       Impact factor: 3.240

Review 5.  Relaxin-2 as a Potential Biomarker in Cardiovascular Diseases.

Authors:  Alana Aragón-Herrera; Sandra Feijóo-Bandín; Laura Anido-Varela; Sandra Moraña-Fernández; Esther Roselló-Lletí; Manuel Portolés; Estefanía Tarazón; Oreste Gualillo; José Ramón González-Juanatey; Francisca Lago
Journal:  J Pers Med       Date:  2022-06-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.